Virax Biolabs Group annual operating margin
2021
2023
2024
2025
2026
Virax Biolabs Group Operating Margin Growth & History (VRAX)
Virax Biolabs Group's operating margin was −51,515.17% for fiscal 2026.
View full Virax Biolabs Group company overviewVirax Biolabs Group annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | −51,515.17% | +45829.59 pp |
| 2025 | 2025-03-31 | −97,344.76% | −93191.51 pp |
| 2024 | 2024-03-31 | −4,153.25% | +62810.43 pp |
| 2023 | 2023-03-31 | −66,963.68% | — |
| 2021 | 2021-03-31 | −520.54% | — |
Virax Biolabs Group operating margin trends
Over the last five fiscal years, Virax Biolabs Group's operating margin decreased from −520.54% to −51,515.17%, a change of −50994.63 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Virax Biolabs Group source filings ↗